UNSPSC 51263111: Bornaprolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66STS87GEY. European Medicines Agency schedules Bornaprolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05875MIG. Bornaprolol generally arises in the molecular formula C19H29NO2. The term BORNAPROLOL is an International Non-Proprietary Name or INN. BORNAPROLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule bornaprolol under HS 29221980 and SITC 51461. As of Q4 2014, BORNAPROLOL remains the US FDA Preferred Term for this commodity. Bornaprolol bears US NLM identifiers UMLS ID C0106915 and NCI Concept Code C90794. SMILES: O(C1C(C2C3CC(C2)CC3)CCCC1)CC(O)CNC(C)C.

UNSPSC 51263111 Bornaprolol (Commodity) does not align with the recent state and local procurement activity tagged under this code. The single recent opportunity shows Seminole County, Florida soliciting naloxone and safe drug deactivation systems through an IFB (IFB60459723LAS, due July 26, 2023), a public-health consumable unrelated to bornaprolol, a beta-blocker pharmaceutical. The mismatch suggests either a data-entry error in the opportunity record or a miscoded solicitation. State and local buyers use UNSPSC codes to classify pharmaceutical procurements by active ingredient or therapeutic class, and this record does not support a decision about demand for bornaprolol specifically under the commodity code.

No additional recent opportunities appear in the source to establish geographic spread, issuing-body concentration, or a representative pattern of bornaprolol procurement at the state and local level. The code shows minimal or misaligned recent activity that does not support a pursuit decision.